Ausgabe 3/2020
Inhalt (63 Artikel)
Why Breast Cancer Risk Models Fail: The Case of Lobular Carcinoma In Situ
- Breast Oncology
David M. Euhus
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin
- Peritoneal Surface Malignancy
Sandy Tun, Oliver S. Eng, Monica Malec
Can Prognosis Be Modified in Pancreatic Cancer?
- Pancreatic Tumors
Motaz Qadan, Carlos Fernandez-del Castillo
Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)
- Health Services Research and Global Oncology
T. J. Stankowski-Drengler, J. R. Schumacher, B. Hanlon, D. Livingston-Rosanoff, K. Van de Walle, C. C. Greenberg, L. G. Wilke, H. B. Neuman
Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital
- Health Services Research and Global Oncology
Michelle Ju, Sam C. Wang, Samira Syed, Deepak Agrawal, Matthew R. Porembka
Clinicopathologic Characteristics of Oligometastases from Esophageal Cancer and Long-Term Outcomes of Resection
- Thoracic Oncology
Yu Ohkura, Junichi Shindoh, Masaki Ueno, Toshiro Iizuka, Harushi Udagawa
ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer
- ASO Author Reflections
Yu Ohkura
Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer
- Thoracic Oncology
Francis I. Macedo, Jose Wilson Mesquita-Neto, Kristin N. Kelly, Basem Azab, Danny Yakoub, Nipun B. Merchant, Alan S. Livingstone, Dido Franceschi
Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB
- Thoracic Oncology
Suna Erdem, Esther Troxler, René Warschkow, Catherine Tsai, Babatunde Yerokun, Bruno Schmied, Christoph Stettler, Dan G. Blazer III, Matthew Hartwig, Mathias Worni, Beat Gloor
ASO Author Reflections: Surgical Resection of Esophageal Neuroendocrine Tumors Should Be Considered as an Integral Part of Multimodal Therapy in Localized Disease
- ASO Author Reflections
Suna Erdem, Mathias Worni
Tooth Loss Predicts Long-Term Prognosis of Esophageal Cancer After Esophagectomy
- Thoracic Oncology
Susumu Miura, Tetsu Nakamura, Takumi Hasegawa, Yukiko Miura, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Satoshi Suzuki, Masaya Akashi, Yoshihiro Kakeji
ASO Author Reflections: Minimally Invasive Esophagectomy for Esophageal Cancer in the Prone and Lateral Position
- ASO Author Reflections
Susumu Miura, Yoshihiro Kakeji
Impact of Lymphadenectomy on Survival After Unimodality Transthoracic Esophagectomy for Adenocarcinoma of Esophagus
- Thoracic Oncology
A. W. Phillips, K. Hardy, M. Navidi, S. K. Kamarajah, A. Madhavan, A. Immanuel, S. M. Griffin
ASO Author Reflections: Lymphadenectomy in Esophagectomy: Why Bother?
- ASO Author Reflections
Alexander W. Phillips, Sivesh K. Kamarajah
Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma
- Thoracic Oncology
Xu-Heng Chiang, Hsao-Hsun Hsu, Min-Shu Hsieh, Chia-Hong Chang, Tung-Ming Tsai, Hsien-Chi Liao, Kuan-Chuan Tsou, Mong-Wei Lin, Jin-Shing Chen
ASO Author Reflections: Sublobar Resection En Route to Becoming the Standard of Care for cT1N0 Lung Adenocarcinoma
- ASO Author Reflections
Mong-Wei Lin, Jin-Shing Chen
Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review
- Open Access
- Thoracic Oncology
Sheraz R. Markar, Jesper Lagergren
The Landmark Series: Axillary Management in Breast Cancer
- Breast Oncology
Carla S. Fisher, Julie A. Margenthaler, Kelly K. Hunt, Theresa Schwartz
Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use
- Breast Oncology
Ko Un Park, Kristin Kyrish, Min Yi, Isabelle Bedrosian, Abigail S. Caudle, Henry M. Kuerer, Kelly K. Hunt, Makesha V. Miggins, Sarah M. DeSnyder
The Tyrer–Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS
- Breast Oncology
Monica G. Valero, Emily C. Zabor, Anna Park, Elizabeth Gilbert, Ashely Newman, Tari A. King, Melissa L. Pilewskie
ASO Author Reflections: Breast Cancer Risk Assessment in Women with LCIS—More Work Is Needed
- ASO Author Reflections
Monica G. Valero, Tari A. King, Melissa L. Pilewskie
Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy
- Breast Oncology
Nicole Christian, Emily C. Zabor, Michael Cassidy, Jessica Flynn, Monica Morrow, Mary L. Gemignani
ASO Author Reflections: Neoadjuvant Chemotherapy for Breast Cancer May Not Alter Increasing Trends for CPM Utilization
- ASO Author Reflections
Nicole Christian, Mary L. Gemignani
Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study
- Breast Oncology
Maria Cristina Leonardi, Luigi Tomio, Davide Radice, Silvia Takanen, Elisabetta Bonzano, Marina Alessandro, Antonella Ciabattoni, Giovanni Battista Ivaldi, Vincenzo Bagnardi, Ombretta Alessandro, Claudia Maria Francia, Cristiana Fodor, Eleonora Miglietta, Paolo Veronesi, Viviana Enrica Galimberti, Roberto Orecchia, Luca Tagliaferri, Cristiana Vidali, Mariangela Massaccesi, Marina Guenzi, Barbara Alicja Jereczek-Fossa
ASO Author Reflections: Repeat Quadrantectomy and Re-irradiation Is Safe and Effective Treatment for Local Recurrence After Partial Breast Irradiation
- ASO Author Reflections
Maria Cristina Leonardi
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
- Open Access
- Breast Oncology
Hatem Soliman, Susanne Wagner, Darl D. Flake II, Mark Robson, Lee Schwartzberg, Priyanka Sharma, Anthony Magliocco, Ralf Kronenwett, Johnathan M. Lancaster, Jerry S. Lanchbury, Alexander Gutin, William Gradishar
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin
- Peritoneal Surface Malignancy
Omeed Moaven, Konstantinos I. Votanopoulos, Perry Shen, Paul Mansfield, David L. Bartlett, Greg Russell, Richard McQuellon, John H. Stewart, Edward A. Levine
ASO Author Reflections: Patient-Reported Outcomes of Mucinous Appendiceal Cancer Improve with Oxaliplatin HIPEC
- ASO Author Reflections
Omeed Moaven, Kathleen C. Perry, Konstantinos I. Votanopoulos, Perry Shen, Edward A. Levine
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
- Peritoneal Surface Malignancy
Jason T. Wiseman, Charles Kimbrough, Eliza W. Beal, Mohammad Y. Zaidi, Charles A. Staley, Travis Grotz, Jennifer Leiting, Keith Fournier, Andrew J. Lee, Sean Dineen, Benjamin Powers, Jula Veerapong, Joel M. Baumgartner, Callisia Clarke, Sameer H. Patel, Vikrom Dhar, Ryan J. Hendrix, Laura Lambert, Daniel E. Abbott, Courtney Pokrzywa, Mustafa Raoof, Byrne Lee, Nadege Fackche, Jonathan Greer, Timothy M. Pawlik, Sherif Abdel-Misih, Jordan M. Cloyd
ASO Author Reflections: Impact of Operative Technique on Anastomotic Failure During Cytoreductive Surgery for Peritoneal Malignancies—Surgeon Preference is Fine
- ASO Author Reflections
Jason T. Wiseman, Jordan M. Cloyd
The Suggestion of Revised Criteria for Endoscopic Resection of Differentiated-Type Submucosal Gastric Cancer
- Peritoneal Surface Malignancy
Dae Won Ma, Seok Joo Lee, Myeong-Cherl Kook, Do Youn Park, Sangjeong Ahn, Keun Won Ryu, Il Ju Choi, Sung Hoon Noh, Hyunki Kim, Yong Chan Lee, Jie-Hyun Kim
Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China
- Gastrointestinal Oncology
Jun Lu, Changhwan Yoon, Binbin Xu, Jianwei Xie, Ping Li, Chaohui Zheng, Changming Huang, Sam S. Yoon
Feasibility and Safety of Early Oral Intake and Discharge After Total or Proximal Gastrectomy: An Analysis of Consecutive Cases Without Exclusion Criteria
- Gastrointestinal Oncology
Masatoshi Nakagawa, Masanori Tokunaga, Tomoki Aburatani, Yuya Sato, Takatoshi Matsuyama, Yasuaki Nakajima, Yusuke Kinugasa
Technique for Robotic Ivor Lewis Esophagectomy with 6-cm Linear Stapled Side-to-Side Anastomosis
- Gastrointestinal Oncology
June S. Peng, Steven J. Nurkin, Steven N. Hochwald, Moshim Kukar
Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome
- Colorectal Cancer
Rodney E. Wegner, Stephen Abel, Dulabh Monga, Moses Raj, Gene Finley, Stanislav Nosik, James McCormick, Alexander V. Kirichenko
Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer
- Open Access
- Colorectal Cancer
Stephen T. McSorley, Alexander Tham, Ross D. Dolan, Colin W. Steele, Jason Ramsingh, Campbell Roxburgh, Paul G. Horgan, Donald C. McMillan
Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer
- Colorectal Cancer
Shinsuke Suzuki, Takashi Akiyoshi, Koji Oba, Fuhito Otsuka, Tetsuro Tominaga, Toshiya Nagasaki, Yosuke Fukunaga, Masashi Ueno
ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer
- ASO Author Reflections
Shinsuke Suzuki, Takashi Akiyoshi
Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors
- Endocrine Tumors
Ian W. Folkert, Andrew J. Sinnamon, Seth J. Concors, Bonita J. Bennett, Douglas L. Fraker, Najjia N. Mahmoud, David C. Metz, Kristen M. Stashek, Robert E. Roses
ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors
- ASO Author Reflections
Ian W. Folkert, Robert E. Roses
Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines
- Hepatobiliary Tumors
Diamantis I. Tsilimigras, Rittal Mehta, Dimitrios Moris, Kota Sahara, Fabio Bagante, Anghela Z. Paredes, Ayesha Farooq, Francesca Ratti, Hugo P. Marques, Silvia Silva, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Razvan Grigorie, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik
ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines—How Can Machine Learning Techniques Help?
- ASO Author Reflections
Diamantis I. Tsilimigras, Timothy M. Pawlik
Fong’s Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial
- Hepatobiliary Tumors
Samira Makhloufi, Anthony Turpin, Mehdi el Amrani, Thierry André, Stéphanie Truant, Jean-Baptiste Bachet, Dewi Vernerey, Mohamed Hebbar
ASO Author Reflections: Fong’s Score in the Era of Modern Strategies for Metastatic Colorectal Cancer
- ASO Author Reflections
Anthony Turpin, Mohamed Hebbar
Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer
- Pancreatic Tumors
Nobuhiko Nakagawa, Suguru Yamada, Fuminori Sonohara, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Daisuke Kobayashi, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera
ASO Author Reflections: The Naples Prognostic Score Predicts Long-Term Survival in Patients with Resected Pancreatic Cancer
- ASO Author Reflections
Nobuhiko Nakagawa, Suguru Yamada, Yasuhiro Kodera
Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer
- Pancreatic Tumors
Pranav Murthy, Mazen S. Zenati, Amr I. Al Abbas, Caroline J. Rieser, Nathan Bahary, Michael T. Lotze, Herbert J. Zeh III, Amer H. Zureikat, Brian A. Boone
ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma
- ASO Author Reflections
Pranav Murthy, Brian A. Boone
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection
- Pancreatic Tumors
Ryan J. Ellis, Jessie W. Ho, Cary Jo R. Schlick, Ryan P. Merkow, David J. Bentrem, Karl Y. Bilimoria, Anthony D. Yang
Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans
- Sarcoma
Hayden Snow, Emma Davies, Dirk C. Strauss, Myles Smith, Andrew J. Hayes
High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer
- Translational Research and Biomarkers
Kei Hagiwara, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Dorgormaa Gantumur, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Hiroshi Tanaka, Akira Watanabe, Norio Kubo, Kenichiro Araki, Yasuo Hosouchi, Ken Shirabe
ASO Author Reflections: Clinical Significance of Large Tenascin C Splice Variants and Annexin A2 for Pancreatic Cancer
- ASO Author Reflections
Kei Hagiwara, Norifumi Harimoto, Ken Shirabe
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors
- Translational Research and Biomarkers
Nobuhiro Nakazawa, Takehiko Yokobori, Kyoichi Kaira, Andrei Turtoi, Seded Baatar, Navchaa Gombodorj, Tadashi Handa, Mariko Tsukagoshi, Yasunari Ubukata, Akiharu Kimura, Norimichi Kogure, Kyoichi Ogata, Toshitaka Maeno, Makoto Sohda, Toshiki Yajima, Kimihiro Shimizu, Akira Mogi, Hiroyuki Kuwano, Hiroshi Saeki, Ken Shirabe
ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer
- ASO Author Reflections
Nobuhiro Nakazawa, Takehiko Yokobori, Andrei Turtoi, Ken Shirabe
Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component
- Translational Research and Biomarkers
Naoto Kishi, Masaoki Ito, Yoshihiro Miyata, Akinori Kanai, Yoshinori Handa, Yasuhiro Tsutani, Kei Kushitani, Yukio Takeshima, Morihito Okada
Indication for Sublobar Resection in cT1N0 Lung Adenocarcinoma is Contentious
- Thoracic Oncology
Xu-Heng Chiang, Mong-Wei Lin, Jin-Shing Chen
Sublobar Resection for Clinical IA Non-Small Cell Lung Cancer: One Size Fits All?
- Thoracic Oncology
Han-Yu Deng
Is There a Role for Surgery in Treating Localized Esophageal Neuroendocrine Tumor?
- Thoracic Oncology
Han-Yu Deng
Reply to the Editor: “Is There a Role of Surgery in Treating Localized Esophageal Neuroendocrine Tumor?”
- Endocrine Tumors
Suna Erdem, Rene Warschkow, Mathias Worni